Search results
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 7 days agoDelhi, May 01, 2024 (GLOBE NEWSWIRE) -- Global CD70 Targeting Therapies Market Opportunity & Clinical Trials Insight 2024 Report Highlights: CD70 Targeting Therapies In Clinical Trials: > 20 TherapiesCD 70 Targeting Therapies Clinical Trials
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 5 days agoModerna/Merck also started two separate mid-stage studies in renal cell carcinoma and...
Good to Know: Grim diagnosis spurs Kent couple to sell possessions, plan RV trip of a lifetime
Akron Beacon Journal· 2 days agoPlan B moves to the top of the list for Mark Dailey and Melissa Cairns after cancer diagnosis. The...
Retirement Systems of Alabama Sells 8,056 Shares of Exelixis, Inc. (NASDAQ:EXEL)
ETF DAILY NEWS· 5 days agoRetirement Systems of Alabama cut its position in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 2.0% during the fourth quarter, according to the company in its most recent disclosure ...
High Response Rates With Gene Therapies for BCG-Unresponsive Bladder Cancer
MedPage Today· 4 days agoThree-fourths of patients had complete responses, which proved to be durable in most cases
Exelixis (NASDAQ:EXEL) Earns “Outperform” Rating from William Blair
ETF DAILY NEWS· 4 days agoWilliam Blair reaffirmed their outperform rating on shares of Exelixis (NASDAQ:EXEL – Free Report) in a report published on Wednesday, RTT News reports. Barclays lowered Exelixis from an overweight ...
Sutent Dosage: Form, Strengths, How to Take, and More
Healthline· 6 days agoSutent is a prescription drug used to treat certain types of cancer. Learn about the drug's dosages, form, strengths, how to take it, and more.
Afinitor interactions: Other medications, alcohol, and more
Medical News Today· 4 days agoAfinitor has interactions with some other drugs and certain supplements. Before you start treatment...
Short Interest in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Rises By 5.6%
ETF DAILY NEWS· 6 days agoIovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) saw a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 48,980,000 shares ...
New York State Common Retirement Fund Sells 5,141 Shares of Iovance Biotherapeutics, Inc....
ETF DAILY NEWS· 5 days agoNew York State Common Retirement Fund trimmed its holdings in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 0.5% during the 4th quarter, according to the company in ...
